Insider · CIK 0001874371

Holtzman Douglas

Reports to the SEC for 1 company · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001874371

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-07-03	Icosavax, Inc.S Sale	Chief Scientific Officer	SSale	−14.3K sh	$8.74	−$125K	292,149
2023-07-03	Icosavax, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+16.4K sh	$1.04	+$17K	306,410
2023-07-03	Icosavax, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−16.4K sh	—	—	28,621
2023-07-03	Icosavax, Inc.S Sale	Chief Scientific Officer	SSale	−2,095 sh	$9.59	−$20.1K	290,054
2023-04-03	Icosavax, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−20.4K sh	—	—	44,977
2023-04-03	Icosavax, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+20.4K sh	$1.04	+$21.3K	310,497
2023-04-03	Icosavax, Inc.S Sale	Chief Scientific Officer	SSale	−20.1K sh	$6.08	−$122K	290,354
2023-04-03	Icosavax, Inc.S Sale	Chief Scientific Officer	SSale	−300 sh	$6.56	−$1,968	290,054
2023-02-15	Icosavax, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+90K sh	—	—	90,000
2023-02-14	Icosavax, Inc.S Sale	Chief Scientific Officer	SSale	−3,349 sh	$10.17	−$34.1K	290,054
2023-02-13	Icosavax, Inc.S Sale	Chief Scientific Officer	SSale	−1,522 sh	$10.69	−$16.3K	293,403
2022-12-15	Icosavax, Inc.S Sale	Chief Scientific Officer	SSale	−19.6K sh	$11.14	−$219K	2,792
2022-11-10	Icosavax, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+82.6K sh	—	—	82,580
2022-08-02	Icosavax, Inc.S Sale	Chief Scientific Officer	SSale	−453 sh	$6.70	−$3,036.821	293,258
2022-08-01	Icosavax, Inc.S Sale	Chief Scientific Officer	SSale	−9,337 sh	$6.64	−$62K	293,711
2022-07-29	Icosavax, Inc.S Sale	Chief Scientific Officer	SSale	−585 sh	$7.11	−$4,157.946	303,048
2022-05-31	Icosavax, Inc.A Award	Chief Scientific Officer	AAward	+1,667 sh	$5.77	+$9,618.59	294,925
2022-02-18	Icosavax, Inc.G Gift	Chief Scientific Officer	GGift	−20K sh	—	—	22,440
2022-02-10	Icosavax, Inc.Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+82K sh	—	—	81,950
2022-02-10	Icosavax, Inc.A Award	Chief Scientific Officer	AAward	+19.5K sh	—	—	303,633
2021-12-31	Icosavax, Inc.G Gift	Chief Scientific Officer	GGift	−10K sh	—	—	42,440
2021-08-02	Icosavax, Inc.Series A-1 Preferred StockC Conversion	Chief Scientific Officer	CConversion	−206K sh	—	—	0
2021-08-02	Icosavax, Inc.Series B-1 Preferred StockC Conversion	Chief Scientific Officer	CConversion	−11.6K sh	—	—	0
2021-08-02	Icosavax, Inc.C Conversion	Chief Scientific Officer	CConversion	+52.4K sh	—	—	52,440
2021-07-30	Icosavax, Inc.A Award	Chief Scientific Officer	AAward	+41.5K sh	$15.00	+$623K	282,482

Recent filings

Accepted (ET)
Jul 34
Holtzman Douglas0001209191-23-040716
SEC(opens sec.gov)
Apr 54
Holtzman Douglas0001209191-23-023467
SEC(opens sec.gov)
Feb 174
Holtzman Douglas0001209191-23-010904
SEC(opens sec.gov)
Feb 154
Holtzman Douglas0001209191-23-009916
SEC(opens sec.gov)
Feb 145
Holtzman Douglas0001209191-23-009242
SEC(opens sec.gov)
Dec 164
Holtzman Douglas0001209191-22-061736
SEC(opens sec.gov)
Nov 144
Holtzman Douglas0001209191-22-056826
SEC(opens sec.gov)
Aug 24
Holtzman Douglas0001209191-22-044021
SEC(opens sec.gov)
Feb 144
Holtzman Douglas0001209191-22-009513
SEC(opens sec.gov)

Companies

Icosavax, Inc.Chief Scientific Officer

Address

C/O ICOSAVAX, INC. 1616 EASTLAKE AVENUE E., SUITE 208

SEATTLE, WA, 98102-3793